![John Markels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Markels
Director/Board Member at
SANGAMO THERAPEUTICS, INC.
Net worth: 11 778 $ as of 31/08/2026
Profile
Dr. John H.
Markels is an Independent Director at Vaxcyte, Inc., an Independent Director at Arcturus Therapeutics Holdings, Inc. and an Independent Director at Sangamo Therapeutics, Inc. He is on the Board of Directors at Vaxcyte, Inc., Arcturus Therapeutics Holdings, Inc., Sangamo Therapeutics, Inc., Arcturus Therapeutics Ltd. and Arcturus Therapeutics, Inc. Dr. Markels was previously employed as a President-Global Vaccines by Merck & Co., Inc. He received his undergraduate degree from the University of Delaware and a doctorate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 71,384 ( 0.02% ) | 11 778 $ | 31/08/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
John Markels active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 11/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 08/12/2022 |
| VAXCYTE, INC. | Director/Board Member | 16/07/2026 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Former positions of John Markels
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/03/2022 |
Training of John Markels
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- John Markels
